These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3081038)

  • 1. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.
    Fujibayashi S; Wenger DA
    Biochim Biophys Acta; 1986 Feb; 875(3):554-62. PubMed ID: 3081038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical, immunological, and structural studies on a sphingolipid activator protein (SAP-1).
    Inui K; Wenger DA
    Arch Biochem Biophys; 1984 Sep; 233(2):556-64. PubMed ID: 6435528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and processing of sphingolipid activator protein-2 (SAP-2) in cultured human fibroblasts.
    Fujibayashi S; Wenger DA
    J Biol Chem; 1986 Nov; 261(32):15339-43. PubMed ID: 3771578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The gene coding for a sphingolipid activator protein, SAP-1, is on human chromosome 10.
    Inui K; Kao FT; Fujibayashi S; Jones C; Morse HG; Law ML; Wenger DA
    Hum Genet; 1985; 69(3):197-200. PubMed ID: 3980013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of GM1 ganglioside in cultured skin fibroblasts: anomalies in gangliosidoses, sialidoses, and sphingolipid activator protein (SAP, saposin) 1 and prosaposin deficient disorders.
    Schmid B; Paton BC; Sandhoff K; Harzer K
    Hum Genet; 1992 Jul; 89(5):513-8. PubMed ID: 1634229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological evidence for deficiency in an activator protein for sulfatide sulfatase in a variant form of metachromatic leukodystrophy.
    Inui K; Emmett M; Wenger DA
    Proc Natl Acad Sci U S A; 1983 May; 80(10):3074-7. PubMed ID: 6134282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degradation of membrane-bound ganglioside GM1. Stimulation by bis(monoacylglycero)phosphate and the activator proteins SAP-B and GM2-AP.
    Wilkening G; Linke T; Uhlhorn-Dierks G; Sandhoff K
    J Biol Chem; 2000 Nov; 275(46):35814-9. PubMed ID: 10942779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiency.
    Rafi MA; Amini S; Zhang XL; Wenger DA
    Am J Hum Genet; 1992 Jun; 50(6):1252-8. PubMed ID: 1350885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD).
    Wrobe D; Henseler M; Huettler S; Pascual Pascual SI; Chabas A; Sandhoff K
    J Inherit Metab Dis; 2000 Feb; 23(1):63-76. PubMed ID: 10682309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, pathological, and biochemical studies on an infantile case of sulfatide/GM1 activator protein deficiency.
    Wenger DA; DeGala G; Williams C; Taylor HA; Stevenson RE; Pruitt JR; Miller J; Garen PD; Balentine JD
    Am J Med Genet; 1989 Jun; 33(2):255-65. PubMed ID: 2764035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
    Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of surfactant-associated glycoprotein A by rat type II epithelial cells. Primary translation products and post-translational modification.
    Whitsett JA; Weaver T; Hull W; Ross G; Dion C
    Biochim Biophys Acta; 1985 Apr; 828(2):162-71. PubMed ID: 2858220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a point mutation in sphingolipid activator protein-1 mRNA in patients with a variant form of metachromatic leukodystrophy.
    Rafi MA; Zhang XL; DeGala G; Wenger DA
    Biochem Biophys Res Commun; 1990 Jan; 166(2):1017-23. PubMed ID: 2302219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the three alternative forms of the sphingolipid activator protein precursor in baby hamster kidney cells and functional assays in a cell culture system.
    Henseler M; Klein A; Glombitza GJ; Suziki K; Sandhoff K
    J Biol Chem; 1996 Apr; 271(14):8416-23. PubMed ID: 8626540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of carbohydrate removal on stability and activity of saposin B.
    Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y
    Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Processing of human acid sphingomyelinase in normal and I-cell fibroblasts.
    Hurwitz R; Ferlinz K; Vielhaber G; Moczall H; Sandhoff K
    J Biol Chem; 1994 Feb; 269(7):5440-5. PubMed ID: 8106525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological relevance of sphingolipid activator proteins in cultured human fibroblasts.
    Sadeghlar F; Remmel N; Breiden B; Klingenstein R; Schwarzmann G; Sandhoff K
    Biochimie; 2003; 85(3-4):439-48. PubMed ID: 12770782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of asparagine-linked sugar chains of sphingolipid activator protein 1 purified from normal human liver and GM1 gangliosidosis (type 1) liver.
    Yamashita K; Inui K; Totani K; Kochibe N; Furukawa M; Okada S
    Biochemistry; 1990 Mar; 29(12):3030-9. PubMed ID: 2110822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
    Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
    Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of a splice-site mutation in the sap-precursor gene of a patient with metachromatic leukodystrophy.
    Henseler M; Klein A; Reber M; Vanier MT; Landrieu P; Sandhoff K
    Am J Hum Genet; 1996 Jan; 58(1):65-74. PubMed ID: 8554069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.